Home
ReferenceStandardsPublished Aug 25, 2026

USP-NF — Structure and How to Navigate Monographs

By the PharmaCountry team

How the USP-NF is organized and how to read a monograph to find the requirements that matter.

USP-NF Structure

The United States Pharmacopeia–National Formulary combines two historically distinct compendia into a single publication, with USP traditionally covering drug substances and drug products while NF traditionally covers excipients, together forming the comprehensive compendial reference most directly relevant to US pharmaceutical quality standards. The combined publication is organized into general chapters, providing broadly applicable test methods and general requirements, and individual monographs, providing substance-specific or product-specific requirements, with these two content types working together rather than functioning as fully independent, disconnected sections of the overall publication.

General Chapters vs Monographs

General chapters describe test methods, procedures, and general requirements applicable across multiple monographs, such as dissolution testing methodology or microbial limits testing procedure, referenced by individual monographs rather than each monograph independently restating the full test method detail. Understanding a specific monograph's requirements genuinely requires reading it alongside every general chapter it references, since a monograph's own text is typically deliberately concise, relying on referenced general chapters to supply the actual detailed test procedure and, in some cases, default acceptance criteria applicable unless the specific monograph states otherwise.

Reading a Monograph

A monograph typically specifies the substance's identity requirements, assay method and acceptance range, related substances or impurity limits, and other substance-specific tests such as physical characteristics or specific functional performance requirements relevant to that particular substance or product category. Reading a monograph correctly requires attention to numbered general chapter references appearing throughout the text, since these references indicate exactly which general chapter method and, where specified, which specific general chapter acceptance criteria apply to that particular monograph requirement, information not always immediately obvious without deliberately tracing every cross-reference the monograph text actually contains.

Staying Current

USP-NF content is revised on an ongoing basis, with new and revised monographs and general chapters becoming official on defined effective dates, meaning companies relying on compendial standards must maintain active awareness of pending and recently finalized revisions relevant to their own specific products and materials, rather than assuming a previously reviewed monograph version remains permanently current without any need for periodic reconfirmation. A specification or test method based on an outdated monograph version can create a genuine compliance gap once a newer official revision actually supersedes the version originally referenced.

Compendial Status and Legal Significance

USP-NF standards carry genuine legal and regulatory significance in the United States, since a drug product or ingredient represented as complying with USP or NF standards must actually meet the current official compendial requirements, and misrepresenting compliance, whether deliberately or through inadequate awareness of current requirements, carries real regulatory consequence beyond simply a technical documentation discrepancy.

Using USP-NF Alongside Other Pharmacopeias

Companies operating globally often need to reference multiple pharmacopeias simultaneously, including USP-NF alongside the European Pharmacopoeia and other regional compendia, discussed further in the related pharmacopeial harmonization article, since a single product marketed across multiple regions may need to demonstrate compliance with each relevant region's own specific compendial requirements, which are not always fully identical despite meaningful ongoing harmonization efforts across major pharmacopeias.

Applying USP-NF to Specification Development

Specification development for a compendial substance or product should begin from the applicable current monograph, incorporating any additional company-specific requirements genuinely needed beyond the compendial baseline, rather than either ignoring applicable compendial requirements entirely or assuming compendial requirements alone are automatically sufficient without any consideration of product-specific or process-specific additional needs the specific product or process might actually present.

Practical Navigation Tools

Modern USP-NF access is typically provided through an online, searchable platform supporting efficient navigation between monographs and their referenced general chapters, along with revision history and pending revision visibility, and companies should ensure personnel responsible for compendial compliance have genuine, current access to this platform rather than relying on potentially outdated printed or locally saved compendial content that may not reflect the actual current official standard.